Fairfield, Bush & Co. Johnson & Johnson Transaction History

Fairfield, Bush & Co.

$168 Billion
Q3 2024

A detailed history of Fairfield, Bush & Co. transactions in Johnson & Johnson stock. As of the latest transaction made, Fairfield, Bush & Co. holds 11,765 shares of JNJ stock, worth $1.82 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

11,765

Previous 12,968 9.28%

Holding current value

$1.82 Million

Previous $1.9 Billion 0.59%

% of portfolio

1.13%

Previous 1.14%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$145.48 - $167.38 $175,012 - $201,358	-1,203 Reduced 9.28%	11,765 $1.91 Billion
Q2 2024 Aug 15, 2024	SELL	$144.38 - $157.78 $190,148 - $207,796	-1,317 Reduced 9.22%	12,968 $1.9 Billion
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $11,641 - $12,205	-75 Reduced 0.52%	14,285 $2.26 Billion
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $155,355 - $169,524	-1,067 Reduced 6.92%	14,360 $2.25 Billion
Q3 2023 Nov 15, 2023	SELL	$155.75 - $174.48 $3.73 Million - $4.18 Million	-23,975 Reduced 60.85%	15,427 $2.4 Billion
Q2 2023 Aug 15, 2023	BUY	$154.35 - $166.11 $132,586 - $142,688	859 Added 2.23%	39,402 $6.52 Billion
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $3.6 Million - $4.3 Million	23,850 Added 162.32%	38,543 $5.97 Billion
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $98,202 - $110,211	-613 Reduced 4.0%	14,693 $2.6 Billion
Q3 2022 Nov 07, 2022	SELL	$161.33 - $179.52 $181,980 - $202,498	-1,128 Reduced 6.86%	15,306 $2.5 Million
Q2 2022 Aug 09, 2022	SELL	$168.19 - $186.01 $305,096 - $337,422	-1,814 Reduced 9.94%	16,434 $2.92 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $127,302 - $144,569	-805 Reduced 4.23%	18,248 $3.23 Million
Q1 2022 May 06, 2022	SELL	$158.14 - $179.59 $11,069 - $12,571	-70 Reduced 0.37%	19,053 $3.38 Million
Q4 2021 Feb 09, 2022	SELL	$155.93 - $173.01 $604,540 - $670,759	-3,877 Reduced 16.86%	19,123 $3.27 Million
Q3 2021 Nov 08, 2021	SELL	$161.5 - $179.47 $3.17 Million - $3.53 Million	-19,654 Reduced 46.08%	23,000 $3.72 Million
Q2 2021 Aug 02, 2021	SELL	$159.48 - $171.07 $271,116 - $290,819	-1,700 Reduced 3.83%	42,654 $7.03 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $19,592 - $21,821	-128 Reduced 0.29%	44,354 $7.29 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $151,506 - $173,904	-1,105 Reduced 2.42%	44,482 $7 Million
Q3 2020 Nov 18, 2020	BUY	$140.38 - $153.83 $139,256 - $152,599	992 Added 2.22%	45,587 $6.79 Million
Q2 2020 Aug 13, 2020	BUY	$128.81 - $155.51 $467,709 - $564,656	3,631 Added 8.86%	44,595 $6.27 Million
Q1 2020 May 13, 2020	BUY	$111.14 - $153.99 $56,347 - $78,072	507 Added 1.25%	40,964 $5.37 Million
Q4 2019 Feb 12, 2020	SELL	$127.5 - $146.44 $19,762 - $22,698	-155 Reduced 0.38%	40,457 $5.9 Million
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $31,737 - $35,535	-250 Reduced 0.61%	40,612 $5.26 Million
Q2 2019 Aug 13, 2019	SELL	$131.15 - $144.24 $231,873 - $255,016	-1,768 Reduced 4.15%	40,862 $5.69 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $457,243 - $508,416	-3,637 Reduced 7.86%	42,630 $5.96 Million
Q4 2018 Feb 11, 2019	BUY	$122.84 - $147.84 $170,501 - $205,201	1,388 Added 3.09%	46,267 $5.97 Million
Q3 2018 Nov 13, 2018	BUY	$121.58 - $142.88 $173,859 - $204,318	1,430 Added 3.29%	44,879 $6.2 Million
Q2 2018 Aug 16, 2018	SELL	$119.4 - $131.76 $169,428 - $186,967	-1,419 Reduced 3.16%	43,449 $5.27 Million
Q1 2018 May 09, 2018	SELL	$125.1 - $148.14 $375 - $444	-3 Reduced 0.01%	44,868 $5.75 Million
Q4 2017 Feb 22, 2018	BUY	$131.22 - $143.62 $125,315 - $137,157	955 Added 2.17%	44,871 $6.27 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $106,294 - $111,146	-821 Reduced 1.84%	43,916 $5.71 Million
Q2 2017 Aug 15, 2017	BUY	N/A	44,737	44,737 $5.92 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.

Account

Fairfield, Bush & Co. Johnson & Johnson Transaction History